Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (4569)	11/1/1999 10:05:00 PM
From: Kevin Podsiadlik	Read Replies (1) \| Respond to of 10293

Wow, Kevin. I took that one to be understood. So you actually agreed with me, but argued just be contrary? The decision was GUMM's to turn the results over to NEJM and then, when NEJM hadn't done so by the beginning of the cold season, it was GUMM's decision to give AJIC (who in the Hell is NJIR) a shot. NJIR was an bit of a mixup with the JIR, which is where I would guess the study probably belongs. That aside, you're essentially admitting, above, that GUMM shopped their study around for a journal that would deliver a publishing commitment within a time frame conducive to maximal PR value. In other words, they value quick and timely hype over true journalistic rigor, which most people around here already knew. Enjoy while you can, just don't forget to sell at the top.